Stock Compensation Plan (Tables)

12 Months Ended

Dec. 31, 2024

Stock Compensation Plan

Schedule of Company's Stock Options

The following table sets forth the activity for the Company’s stock options during the periods presented:

	Number of Options			Weighted- Average Exercise Price per Share		Weighted Average Remaining Contractual Term (in Years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2022		2,901,000		$	1.91		9.4	$	199,500
Granted		—		$	—
Forfeited		(135,000	)	$	2.00
Outstanding as of December 31, 2023		2,766,000		$	1.91		8.4	$	231,000
Granted		—		$	—
Forfeited		(35,000	)	$	2.00
Outstanding as of December 31, 2024		2,731,000		$	1.90		7.4	$	7,171,930
Exercisable as of December 31, 2024		2,339,807		$	1.89		7.4	$	6,182,213
Vested or expected to vest as of December 31, 2024		2,731,000		$	1.90		7.4	$	7,171,930

Schedule of Summarizes Vesting of Restricted Common Stock

The following table summarizes awards and vesting of restricted common stock:

	Number of Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2022		7,000,000		$	1.75
Granted		1,756,750		$	1.52
Vested		(4,267,564	)	$	1.84
Unvested as of December 31 2023		4,489,186		$	1.42
Granted		2,523,554		$	3.79
Vested		(3,873,037	)	$	1.76
Forfeited and retired		(325,000	)	$	1.19
Unvested as of December 31 2024		2,814,703		$	3.24

Of the 2,523,554 shares of restricted common stock granted in 2024, 150,000 shares were issued to consultants and 170,088 shares were issued to the Company's non-employee board members.

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for all stock awards recognized in the accompanying consolidated statements of operations is as follows:

	Year Ended December 31,
	2024		2023
Selling, general and administrative	$	8,231,386	$	8,378,875
Research and development		330,018		364,924
Total	$	8,561,404	$	8,743,799